Last reviewed · How we verify

NCT05585853: Virtual

The Effect of Virtual Reality Glasses on Pain Level and Hemo-Dynamic Variables After Open Heart Surgery

Completed NA Last updated 23 September 2025
What this trial tests

NA trial testing virtual reality in Pain in 82 participants. Completed in 26 August 2025.

Timeline
1 January 2025
Primary endpoint
1 January 2025
26 August 2025

Quick facts

Lead sponsorMersin University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment82
Start date1 January 2025
Primary completion1 January 2025
Estimated completion26 August 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Mersin University

Who can join

Adults 18 to 80, any sex, with Pain or Hemodynamic Instability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, between 1 January 2025 - 1 June 2025, who met the inclusion and exclusion criteria, a total of 82 patients who are on the 2nd or 3rd day after the surgery and who are hospitalized in the cardiovascular surgery intensive care clinic will be recruited.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of virtual reality

Trials testing the same drug.

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Mersin University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05585853.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing